Follow
Dinesh Thummuri
Title
Cited by
Cited by
Year
A selective BCL-XL PROTAC degrader achieves safe and potent antitumor activity
S Khan, X Zhang, D Lv, Q Zhang, Y He, P Zhang, X Liu, D Thummuri, ...
Nature medicine 25 (12), 1938-1947, 2019
3982019
Using proteolysis-targeting chimera technology to reduce navitoclax platelet toxicity and improve its senolytic activity
Y He, X Zhang, J Chang, HN Kim, P Zhang, Y Wang, S Khan, X Liu, ...
Nature communications 11 (1), 1996, 2020
1802020
Piperlongumine, an alkaloid causes inhibition of PI3 K/Akt/mTOR signaling axis to induce caspase-dependent apoptosis in human triple-negative breast cancer cells
S Shrivastava, P Kulkarni, D Thummuri, MK Jeengar, VGM Naidu, ...
Apoptosis 19, 1148-1164, 2014
1482014
Thymoquinone prevents RANKL-induced osteoclastogenesis activation and osteolysis in an in vivo model of inflammation by suppressing NF-KB and MAPK Signalling
D Thummuri, MK Jeengar, S Shrivastava, H Nemani, RN Ramavat, ...
Pharmacological Research 99, 63-73, 2015
1232015
Design and synthesis of dithiocarbamate linked β-carboline derivatives: DNA topoisomerase II inhibition with DNA binding and apoptosis inducing ability
A Kamal, M Sathish, VL Nayak, V Srinivasulu, B Kavitha, Y Tangella, ...
Bioorganic & medicinal chemistry 23 (17), 5511-5526, 2015
902015
Synthesis and biological evaluation of new benzimidazole-thiazolidinedione hybrids as potential cytotoxic and apoptosis inducing agents
P Sharma, TS Reddy, D Thummuri, KR Senwar, NP Kumar, VGM Naidu, ...
European journal of medicinal chemistry 124, 608-621, 2016
892016
Long-term gemcitabine treatment reshapes the pancreatic tumor microenvironment and sensitizes murine carcinoma to combination immunotherapy
DR Principe, M Narbutis, S Kumar, A Park, N Viswakarma, MJ Dorman, ...
Cancer research 80 (15), 3101-3115, 2020
882020
Cardamonin, a chalcone, inhibits human triple negative breast cancer cell invasiveness by downregulation of Wnt/β‐catenin signaling cascades and reversal of epithelial …
S Shrivastava, MK Jeengar, D Thummuri, A Koval, VL Katanaev, ...
Biofactors 43 (2), 152-169, 2017
862017
Uridine ameliorates dextran sulfate sodium (DSS)-induced colitis in mice
MK Jeengar, D Thummuri, M Magnusson, VGM Naidu, S Uppugunduri
Scientific Reports 7 (1), 3924, 2017
832017
Cellular senescence and radiation-induced pulmonary fibrosis
Y He, D Thummuri, G Zheng, P Okunieff, DE Citrin, Z Vujaskovic, D Zhou
Translational Research 209, 14-21, 2019
802019
DT2216—a Bcl-xL-specific degrader is highly active against Bcl-xL-dependent T cell lymphomas
Y He, R Koch, V Budamagunta, P Zhang, X Zhang, S Khan, D Thummuri, ...
Journal of hematology & oncology 13, 1-13, 2020
752020
Development of a BCL-xL and BCL-2 dual degrader with improved anti-leukemic activity
D Lv, P Pal, X Liu, Y Jia, D Thummuri, P Zhang, W Hu, J Pei, Q Zhang, ...
Nature communications 12 (1), 6896, 2021
732021
Discovery of PROTAC BCL-XL degraders as potent anticancer agents with low on-target platelet toxicity
X Zhang, D Thummuri, X Liu, W Hu, P Zhang, S Khan, Y Yuan, D Zhou, ...
European journal of medicinal chemistry 192, 112186, 2020
722020
New (E)-1-alkyl-1H-benzo [d] imidazol-2-yl) methylene) indolin-2-ones: Synthesis, in vitro cytotoxicity evaluation and apoptosis inducing studies
P Sharma, D Thummuri, TS Reddy, KR Senwar, VGM Naidu, ...
European journal of medicinal chemistry 122, 584-600, 2016
692016
Design, synthesis and apoptosis inducing effect of novel (Z)-3-(3′-methoxy-4′-(2-amino-2-oxoethoxy)-benzylidene) indolin-2-ones as potential antitumour agents
KR Senwar, TS Reddy, D Thummuri, P Sharma, VGM Naidu, ...
European journal of medicinal chemistry 118, 34-46, 2016
672016
Synthesis and biological evaluation of new rhodanine analogues bearing 2-chloroquinoline and benzo [h] quinoline scaffolds as anticancer agents
V Ramesh, BA Rao, P Sharma, B Swarna, D Thummuri, K Srinivas, ...
European Journal of Medicinal Chemistry 83, 569-580, 2014
652014
Carnosic acid attenuates RANKL-induced oxidative stress and osteoclastogenesis via induction of Nrf2 and suppression of NF-κB and MAPK signalling
D Thummuri, VGM Naidu, P Chaudhari
Journal of Molecular Medicine 95, 1065-1076, 2017
642017
Utilizing PROTAC technology to address the on-target platelet toxicity associated with inhibition of BCL-XL
X Zhang, D Thummuri, Y He, X Liu, P Zhang, D Zhou, G Zheng
Chemical Communications 55 (98), 14765-14768, 2019
622019
Review on emu products for use as complementary and alternative medicine
MK Jeengar, PS Kumar, D Thummuri, S Shrivastava, L Guntuku, R Sistla, ...
Nutrition 31 (1), 21-27, 2015
502015
IITZ-01, a novel potent lysosomotropic autophagy inhibitor, has single-agent antitumor efficacy in triple-negative breast cancer in vitro and in vivo
L Guntuku, JK Gangasani, D Thummuri, RM Borkar, B Manavathi, ...
Oncogene 38 (4), 581-595, 2019
432019
The system can't perform the operation now. Try again later.
Articles 1–20